Formyl-peptide receptors revisited

被引:518
作者
Le, YY
Murphy, PM
Wang, JM
机构
[1] NCI, CCR, LMI, Frederick, MD 21702 USA
[2] NIAID, Lab Host Def, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S1471-4906(02)02316-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors. The first chemotactic factors to be structurally defined were the N-formyl peptides. Unlike other leukocyte chemoattractants, N-formyl peptides could originate from either an endogenous source, such as the mitochondrial proteins of ruptured host cells, or an exogenous source, such as the proteins of invading pathogens. This suggests that the formyl-peptide receptor (FPR) and its variant FPRL1 (FPR-like 1) are involved in host defense against bacterial infection and in the clearance of damaged cells. Recently, additional, more complex, roles for these receptors have been proposed because FPR, and to a greater extent FPRL1, have been found to interact with a menagerie of structurally diverse pro- and anti-inflammatory ligands associated with different diseases, including amyloidosis, Alzheimer's disease, prion disease and HIV How these receptors recognize such diverse ligands, which are the most important in vivo, and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that could lead to new therapeutic targets.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 65 条
[21]   Selectivity of recombinant human leukotriene D4, leukotriene B4, and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses [J].
Gronert, K ;
Martinsson-Niskanen, T ;
Ravasi, S ;
Chiang, N ;
Serhan, CN .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) :3-9
[22]   Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis [J].
Gwinn, MR ;
Sharma, A ;
De Nardin, E .
JOURNAL OF PERIODONTOLOGY, 1999, 70 (10) :1194-1201
[23]   Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1α-initiated neutrophil responses and trafficking:: Regulators of a cytokine-chemokine axis [J].
Hachicha, M ;
Pouliot, M ;
Petasis, NA ;
Serhan, CN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1923-1929
[24]   N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes:: Molecular characterization of FPR2, a second mouse neutrophil FPR [J].
Hartt, JK ;
Barish, G ;
Murphy, PM ;
Gao, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :741-747
[25]   FMLP actions and its binding sites in isolated human coronary arteries [J].
Keitoku, M ;
Kohzuki, M ;
Katoh, H ;
Funakoshi, M ;
Suzuki, S ;
Takeuchi, M ;
Karibe, A ;
Horiguchi, S ;
Watanabe, J ;
Satoh, S ;
Nose, M ;
Abe, K ;
Okayama, H ;
Shirato, K .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (03) :881-894
[26]   Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry [J].
Kilby, JM ;
Hopkins, S ;
Venetta, TM ;
DiMassimo, B ;
Cloud, GA ;
Lee, JY ;
Alldredge, L ;
Hunter, E ;
Lambert, D ;
Bolognesi, D ;
Mathews, T ;
Johnson, MR ;
Nowak, MA ;
Shaw, GM ;
Saag, MS .
NATURE MEDICINE, 1998, 4 (11) :1302-1307
[27]  
Le Y, 2000, J NEUROSCI, V21, P1
[28]   Expression of functional formyl peptide receptors by human astrocytoma cell lines [J].
Le, YY ;
Hu, JY ;
Gong, WH ;
Shen, WP ;
Li, BQ ;
Dunlop, NM ;
Halverson, DO ;
Blair, DG ;
Wang, JM .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) :102-108
[29]   Cutting edge:: The neurotoxic prion peptide fragment PrP106-126 is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1 [J].
Le, YY ;
Yazawa, H ;
Gong, WH ;
Yu, ZX ;
Ferrans, VJ ;
Murphy, PM ;
Wang, JM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1448-1451
[30]   Pleiotropic roles of formyl peptide receptors [J].
Le, YY ;
Oppenheim, JJ ;
Wang, JM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (01) :91-105